Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapy
Courtney B Rubin1, Rosalie Elenitsas2, Laura Taylor3
1Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania.
Journal of the American Academy of Dermatology
|October 18, 2016
Abstract
No abstract available in PubMed .
More Related Videos
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
12.8K
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.9K
